Stay updated on Nivolumab for HTLV-Associated T-Cell Leukemia/Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab for HTLV-Associated T-Cell Leukemia/Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab for HTLV-Associated T-Cell Leukemia/Lymphoma Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    A consolidated Locations section now lists Maryland, New York, and Ohio sites, with the separate 'Maryland Locations', 'New York Locations', and 'Ohio Locations' entries removed, and the page updated to revision v3.3.3.
    Difference
    0.4%
    Check dated 2025-12-24T15:27:35.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    No Change Detected
  5. Check
    40 days ago
    Change Detected
    Summary
    The Publications text updated to say publications are automatically filled in from PubMed (not just 'come from PubMed'), and the revision tag changed from v3.2.0 to v3.3.2; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-25T21:16:05.000Z thumbnail image
  6. Check
    47 days ago
    Change Detected
    Summary
    The notice about government funding lapse and NIH Clinical Center operating status was removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-18T19:04:35.000Z thumbnail image
  7. Check
    68 days ago
    Change Detected
    Summary
    The update appears limited to timestamp fields and minor UI adjustments, while core study details remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-10-28T02:28:56.000Z thumbnail image
  8. Check
    90 days ago
    Change Detected
    Summary
    Core content updated: a government funding and operating status notice has been added and the version updated to v3.2.0; the prior v3.1.0 tag was removed.
    Difference
    3%
    Check dated 2025-10-06T15:51:56.000Z thumbnail image
  9. Check
    97 days ago
    Change Detected
    Summary
    - Updated version from v3.0.2 to v3.1.0. - No other content changes detected.
    Difference
    0.1%
    Check dated 2025-09-29T09:49:10.000Z thumbnail image

Stay in the know with updates to Nivolumab for HTLV-Associated T-Cell Leukemia/Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab for HTLV-Associated T-Cell Leukemia/Lymphoma Clinical Trial page.